These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15611130)

  • 141. Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.
    Hindi SM; Mishra V; Bhatnagar S; Tajrishi MM; Ogura Y; Yan Z; Burkly LC; Zheng TS; Kumar A
    FASEB J; 2014 Mar; 28(3):1398-411. PubMed ID: 24327607
    [TBL] [Abstract][Full Text] [Related]  

  • 142. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 143. TWEAK-Fn14 as a mediator of acute kidney injury.
    Weinberg JM
    Kidney Int; 2011 Jan; 79(2):151-3. PubMed ID: 21191390
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Fibroblast growth factor inducible 14 signaling facilitates anti-dsDNA IgG penetration into mesangial cells.
    Li R; Jia F; Ren K; Luo M; Min X; Xiao S; Xia Y
    J Cell Physiol; 2021 Jan; 236(1):249-259. PubMed ID: 32542768
    [TBL] [Abstract][Full Text] [Related]  

  • 145. The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.
    Tajrishi MM; Sato S; Shin J; Zheng TS; Burkly LC; Kumar A
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1219-1224. PubMed ID: 24680686
    [TBL] [Abstract][Full Text] [Related]  

  • 146. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways.
    Di Martino L; Osme A; Kossak-Gupta S; Pizarro TT; Cominelli F
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):427-446. PubMed ID: 31181286
    [TBL] [Abstract][Full Text] [Related]  

  • 147. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
    Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A
    J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.
    Güner G; Aßfalg M; Zhao K; Dreyer T; Lahiri S; Lo Y; Slivinschi BI; Imhof A; Jocher G; Strohm L; Behrends C; Langosch D; Bronger H; Nimsky C; Bartsch JW; Riddell SR; Steiner H; Lichtenthaler SF
    EMBO Mol Med; 2022 Oct; 14(10):e16084. PubMed ID: 36069059
    [TBL] [Abstract][Full Text] [Related]  

  • 149. TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair.
    Yang M; Ge H; Ji S; Li Y; Xu L; Bi Z; Bu B
    Rheumatology (Oxford); 2023 Nov; 62(11):3732-3741. PubMed ID: 36916753
    [TBL] [Abstract][Full Text] [Related]  

  • 150. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.
    Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR
    Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232
    [TBL] [Abstract][Full Text] [Related]  

  • 151. DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.
    Tajrishi MM; Shin J; Hetman M; Kumar A
    J Biol Chem; 2014 Jul; 289(29):19985-99. PubMed ID: 24895120
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy.
    Zaitseva O; Hoffmann A; Otto C; Wajant H
    Front Pharmacol; 2022; 13():935086. PubMed ID: 36339601
    [TBL] [Abstract][Full Text] [Related]  

  • 153. The TWEAK/Fn14/CD163 axis-implications for metabolic disease.
    Ratajczak W; Atkinson SD; Kelly C
    Rev Endocr Metab Disord; 2022 Jun; 23(3):449-462. PubMed ID: 34542797
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.
    Li J; Gong LY; Song LB; Jiang LL; Liu LP; Wu J; Yuan J; Cai JC; He M; Wang L; Zeng M; Cheng SY; Li M
    Am J Pathol; 2010 Feb; 176(2):699-709. PubMed ID: 20035051
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.
    Liu ZC; Zhou QL
    Inflamm Res; 2012 Apr; 61(4):277-84. PubMed ID: 22297307
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.
    Bourguignon LYW; Xia W; Wong G
    J Biol Chem; 2009 Jan; 284(5):2657-2671. PubMed ID: 19047049
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis.
    de Moissac D; Zheng H; Kirshenbaum LA
    J Biol Chem; 1999 Oct; 274(41):29505-9. PubMed ID: 10506215
    [TBL] [Abstract][Full Text] [Related]  

  • 158. The role of TWEAK/Fn14 in cardiac remodeling.
    Ren MY; Sui SJ
    Mol Biol Rep; 2012 Nov; 39(11):9971-7. PubMed ID: 22752727
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Deletion of TNF-like weak inducer of apoptosis (TWEAK) protects mice from adipose and systemic impacts of severe obesity.
    Bennett G; Strissel KJ; DeFuria J; Wang J; Wu D; Burkly LC; Obin MS
    Obesity (Silver Spring); 2014 Jun; 22(6):1485-94. PubMed ID: 24616441
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.
    Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C
    Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.